Kate Korson Inspiring Journey: Kate Korson was diagnosed with stage 3 triple-negative breast cancer at 34 years old. She was living her dream of caring for rescued horses in Colorado when she got the news. How am I 34 years old with stage 3 breast cancer? She was puzzled as she tried to understand the situation. What’s wrong with me?
Triple-negative breast cancer is rare and severe, with only 1015% of cases being triple-negative. This complicates Kate’s matter further. This cancer is harder to treat as it lacks receptors most drugs target. The cancer reaching stage 3, spreading to lymph nodes or muscles outside the breast, made fighting harder.
After the terrible news, Kate decided to get care in Pennsylvania. She visited Penn Medicine Abramson Cancer Center. Interestingly, it was the same place her mother had been treated for colon cancer 17 years ago. This link made her experience more meaningful.
Like her mother, Kate wanted to join a clinical study during her cancer battle. She aimed to enhance her odds against the disease and advance breast cancer care for others in similar situations. She said, “I want to help people in the future who have to deal with this.” I want things to be easier for them.
She chose to do this and joined the I-SPY2 clinical trial at Penn Medicine Abramson Cancer Center. In the experiment, Kate received a new cancer treatment faster and safer than the standard treatment. Dr. Hayley Knollman emphasized that the standard treatment for triple-negative breast cancer is six months of intense chemotherapy and immunotherapy. Because she participated in the clinical study, we treated her breast cancer faster and with fewer side effects.
The study results were terrific. After a few months, Kate’s tumour shrank significantly, prompting doctors to cease medication and proceed with surgery to remove the remaining cancerous tissue. Dr. Lola Fayanju, a breast surgeon, said, “She had a great response on pathology…all that tumour was gone.”
After successful surgery, Kate started radiation treatment for a few weeks. She was given a treatment drug to reduce cancer recurrence risk.
Kate’s story is unique in many ways but has a general message. It highlights the significance of clinical trials in advancing medical knowledge and treatments. It emphasizes the need for greater awareness of breast cancer treatment options. Dr. Fayanju and Dr. Knollman are on the medical team. They believe her story will inspire people to prioritize their health and consider clinical trials.
Dr. Fayanju emphasized that breast cancer can affect women of all ages, including the young. If you’re a woman, be aware of your body and determine if you’re at high or average risk.
Per 2023 U.S. Preventive Services Task Force guidelines, mammography screenings for American women should begin at age 40. Dr. Knollman discussed breast cancer prevalence. Each year, around 240,000 women develop breast cancer, per the CDC. She advised women to educate themselves about their bodies and promptly consult their doctors if they had any concerns.
Kate Korson’s story is a source of hope for those with breast cancer. It emphasizes the importance of early cancer detection, personalized treatment plans, and transformative clinical studies.
ALSO READ: Erythritol Health Risks: Links Sugar Substitute to Blood Clots, Heart Attacks, and Strokes
Our Reader’s Queries
Who is Kate Korson?
At just 34 years old, Kate Korson’s world was turned upside down when she was diagnosed with stage 3, triple-negative breast cancer. Despite living out her dream of caring for rescue horses in Colorado and preparing to celebrate her birthday, Kate was hit with the unexpected news.